Channel Therapeutics Corp...

NYSE: PTHS · Real-Time Price · USD
22.73
0.14 (0.62%)
At close: Aug 26, 2025, 1:16 PM
22.60
-0.59%
After-hours: Aug 26, 2025, 06:00 PM EDT

Channel Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023 FY 2022
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022
Cash & Equivalents
513.44K 96.39K 55.07K
Short-Term Investments
n/a n/a n/a
Long-Term Investments
n/a n/a n/a
Other Long-Term Assets
n/a n/a n/a
Receivables
40.4K n/a n/a
Inventory
n/a n/a n/a
Other Current Assets
750K n/a n/a
Total Current Assets
1.37M 96.39K 55.07K
Property-Plant & Equipment
n/a n/a n/a
Goodwill & Intangibles
n/a n/a n/a
Total Long-Term Assets
n/a n/a n/a
Total Assets
1.37M 96.39K 55.07K
Account Payables
1.9M 4.62M 2.99M
Deferred Revenue
n/a n/a n/a
Short-Term Debt
2.19M 1.27M 540.43K
Other Current Liabilities
n/a 645.95K 221.88K
Total Current Liabilities
4.08M 6.54M 3.76M
Long-Term Debt
n/a n/a n/a
Other Long-Term Liabilities
n/a n/a n/a
Total Long-Term Liabilities
n/a n/a n/a
Total Liabilities
4.08M 6.54M 3.76M
Total Debt
2.19M 1.27M 540.43K
Common Stock
613.00 391.00 111.00
Retained Earnings
-21.47M -13.52M -6.14M
Comprehensive Income
n/a n/a n/a
Shareholders Equity
-2.71M -6.44M -3.71M
Total Investments
n/a n/a n/a